Rare diseases
Investigational molecules
Locations
Back to France785 clinical trials in Chambery, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Bepirovirsen for Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue Treatment
FranceStudy on Dexamethasone and Sodium Chloride for Treating Severe Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile
FranceStudy of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors
FranceStudy on the Safety and Effectiveness of Vidutolimod and Cemiplimab for Adults with Advanced or Metastatic Cancer
FranceStudy on the Effectiveness and Safety of AZD4604 for Adults with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
FranceStudy on the Safety and Effectiveness of Cibotercept (KER-012) with Other Drugs for Adults with Pulmonary Arterial Hypertension
FranceStudy Comparing Radium-223 Dichloride with Abiraterone Acetate, Enzalutamide, and Prednisone in Patients with Advanced Prostate Cancer Spread to the Bone
FranceStudy on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines
FranceStudy of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer
FranceStudy on Long-Term Safety of Depemokimab for Adults and Adolescents with Severe Eosinophilic Asthma
FranceStudy of Isatuximab, Lenalidomide, and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple myeloma and various lymphomas, evaluating novel therapeutic combinations and treatment strategies.
Advanced trials exploring combinations of immunotherapy and targeted treatments for blood cancers.
Studies examining innovative treatments for non-small cell lung cancer, particularly focusing on immunotherapy approaches.
Emphasis on improving treatment outcomes through targeted and combination therapies.
Research on pneumococcal vaccines and preventive treatments, including studies in specialized patient populations.
Focus on vaccine effectiveness during acute illness conditions.
Clinical trials examining treatments for hormone-sensitive breast cancer, including targeted therapies and hormone treatment optimization.
Investigation of personalized treatment approaches based on molecular markers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
